23.9 C
New York
Thursday, June 18, 2026

Tag: cell

Advent Technologies Holdings, Inc. Enhances License to Groundbreaking Ion Pair Technology Developed at Los Alamos National Laboratory by Acquiring Exclusivity in Marine, Aviation, and...

LIVERMORE, Calif., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Advent Technologies Holdings, Inc. (NASDAQ: ADN), an innovation-driven company in the fuel cell and hydrogen technology space, announced today that it has entered into a new enhanced license agreement with TRIAD National Security for the Ion Pair technology originally developed at Los Alamos National Laboratory. In the new enhanced license, Advent acquired exclusivity to the technology in the marine, aviation, and portable power fields while retaining its non-exclusive rights in all other fields.

MedTech Manufacturer Juvent Joins the Inc. 5000 List of America’s Fastest-Growing Private Companies

Juvent joins the 2025 Inc. 5000, ranking #757 with 552% growth over 3 years, for its Micro-Impact Platform, which improves mobility, pain, and wellness.

Fuel Cell Market to Grow at a CAGR of 22.1% from 2025 to 2032 | SkyQuest Technology Consulting

The fuel cell market is anticipated to increase, due to the growing concerns about climate change and carbon emissions, are driving the adoption of...

VEON’s Kyivstar Delivers First Messages via Starlink in Direct to Cell Satellite Connectivity Test in Ukraine

Dubai and Kyiv, August 12, 2025 – VEON Ltd. (Nasdaq: VEON), a global digital operator, today announces that Kyivstar, its digital operator in Ukraine, has successfully conducted a test of satellite and terrestrial network integration using Starlink Direct to Cell technology. This is the first field test of of Starlink Direct to Cell in eastern Europe. 

Anixa Biosciences Announces Issuance of Additional U.S. Patent for CAR-T Technology

Newly issued patent extends protection of proprietary solid tumor CAR-T platform to 2045 SAN JOSE, Calif., Aug. 12, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa"...

Rapid Micro Biosystems Reports Second Quarter 2025 Financial Results

LEXINGTON, Mass., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced its financial results for the second quarter ended June 30, 2025.

Klotho Neurosciences, Inc. (KLOTHO) Initiates Manufacturing of KLTO-202 Product Candidate Using AAVnerGene’s Platform Technology

NEW YORK, Aug. 12, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (Nasdaq: KLTO), announces that it signed a binding agreement to initiate manufacturing and development...

WuXi Biologics’ WuXiUP™ Accomplishes Automated Continuous Drug Substance Production at Pilot-Scale

Building on its success in developing continuous production at pilot-scale with the WuXiUP™ platform, WuXi Biologics has further enhanced the technology to achieve automated continuous...

Fosun Pharma’s Small Molecule Innovative Drug XH-S004 Achieves Overseas Licensing for a Potential Total of $645 Million

SHANGHAI, Aug. 11, 2025 /PRNewswire/ -- On August 11, Fosun Pharma (SSE:600196, HKEX: 02196) announced that its subsidiary Fosun Pharma Industrial has signed a License...

Chadwick S. Richard, M.D. Now Offering patients the Hybrid Choice™ Concierge Program from Concierge Choice Physicians

Chadwick S. Richard, M.D., an Internal medicine physician from Medical Clinic of Houston, gives patients the option for more time, service and exclusive one-to-one connectivity...

InventHelp Inventor Develops Versatile Product for Outdoor Enthusiasts (CHK-2275)

PITTSBURGH, Aug. 11, 2025 /PRNewswire/ -- "I wanted to create a versatile product for outdoor enthusiasts that can be used to dry footwear, warm...

Booking Health Unveils New Study: Role of Immunotherapy in Extending Life Expectancy for Stage4 Cervical Cancer Patients

Langenfeld, Germany, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Booking Health, a global leader in medical treatment coordination, today unveiled a new study titled Role of Immunotherapy in Extending Life Expectancy for Stage 4 Cervical Cancer Patients. The report outlines how cutting-edge immunotherapy is reshaping care for women with advanced cervical cancer, offering new pathways to longer survival and improved quality of life, particularly in cases resistant to standard treatments.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsCell